Kalpataru Projects International Limited is an enticing option for investors, with a buying range of ₹1170 to ₹1200 and a projected target of ₹1340 over a 3-month duration. This stock presents an opportunity for potential growth in your investment portfolio. With a stop loss at ₹1095, it's important to assess the risk and potential gains carefully. Stay tuned to financial news for updates on this dynamic investment opportunity. #StockMarket #Investment #FinancialNews share Kalpataru Projects International Limited is an enticing option for investors, with a buying range of ₹1170 to ₹1200 and a projected target of ₹1340 over a 3-month duration. This stock presents an opportunity for potential growth in your investment portfolio. With a stop loss at ₹1095, it’s important to assess the risk and potential gains carefully. Stay tuned to financial news for updates on this dynamic investment opportunity. #StockMarket #Investment #FinancialNews share
Related Posts
RITES Ltd recieve an order worth Rs. 100 Crore approx from Adami Ports & SEZ Limited. #Financial #FinancialNews https://ift.tt/9C7n6HT RITES Ltd recieve an order worth Rs. 100 Crore approx from Adami Ports & SEZ Limited. #Financial #FinancialNews https://ift.tt/9C7n6HT
- Raj Gaurav Rai
- September 28, 2024
RITES Ltd recieve an order worth Rs. 100 Crore approx from Adami Ports & SEZ Limited. #Financial #FinancialNews https://ift.tt/9C7n6HT RITES Ltd recieve an order worth […]
📊 October 13, 2026 Stocks: Reliance ₹2,407, Apple $229 | #7583 | Live BSE NYSE Prices
- Raj Gaurav Rai
- October 13, 2026
Today’s stock market update: ⚖️ Mixed sentiment across Indian and US markets as investors track earnings, Fed policy, and global economic data. Live price tracking […]
Life Insurance Corporation of India likely has reduced its stake in Zydus Lifesciences by 2.0% through an open market sale. Following the stake sale, the insurance company holds 3.157% in Zydus Lifesciences #Investment #StockMarket #FinancialNews Life Insurance Corporation of India likely has reduced its stake in Zydus Lifesciences by 2.0% through an open market sale. Following the stake sale, the insurance company holds 3.157% in Zydus Lifesciences #Investment #StockMarket #FinancialNews
- Raj Gaurav Rai
- August 13, 2024
Life Insurance Corporation of India likely has reduced its stake in Zydus Lifesciences by 2.0% through an open market sale. Following the stake sale, the […]